Objective. Previous studies in an experimental synovitis model in rats dete
rmined that administration of glutamate and aspartate into the joint produc
es hyperalgesic responses, while their receptor antagonists provide protect
ion against the development of a hyperalgesic state. We examined concentrat
ions of amino acids in synovial fluid (SF) to determine if increases might
be relevant to human joint pathology.
Methods. One hundred forty-four repository SF samples from patients undergo
ing diagnostic or therapeutic arthrocentesis and 14 SF samples from 7 cadav
ers were analyzed by high pressure liquid chromatography and compared as ar
thritic and control cohorts.
Results. Compared to the average concentrations from the autopsy cases, the
excitatory amino acids (EAA) glutamate and aspartate in SF from patients w
ith synovitis were 54 and 28 times higher, respectively. Increases for all
other amino acids ranged from 3 to 18-fold, The values for glutamate and as
partate were significantly higher than the mean increase for other amino ac
ids compared using unpaired t tests (p < 0.0001). The mean ratio of glutama
te and aspartate elevations over the mean increase for other amino acids wa
s 4-fold and 2-fold, respectively. The EAA were highest in Reiter's, infect
ious arthropathies, and systemic lupus erythematosus, but did not appreciab
ly segregate to diagnosis or SF white blood cell count.
Conclusion. Our data provide evidence of increased glutamate and aspartate
in the SF of humans with active arthritis, suggesting that glutamate mediat
ed events may contribute to the pathogenesis of human arthritic conditions.